Welcome to Glaucoma Now
Glaucoma Now is set up as a continuing medical education publication.
Based on the information that can be found in each of our electronic issues, we offer an associated e-learning course. Each multiple choice test is divided into the following sections:
Distributed worldwide, our goal is to educate and update general ophthalmologists, glaucoma specialists and ophthalmology residents. International leaders in the field of glaucoma are invited to contribute to this journal, sharing their most recent insights.
Supported by an unrestricted educational grant from Allergan Inc., the publication is non-promotional and has a fully independent Editorial Board. Supporting companies are: Allergan plc, Mundipharma Australia, Novartis Pharmaceuticals Australia Pty Ltd, and Pfizer Inc.
Individual issues of Glaucoma Now are accredited for Continuing Medical Education (CME) by the Physicians' Chamber of Baden-Württemberg, Germany (Local Medical Responsible: Andreas Buchholz, MD, PhD, ROph). This accreditation automatically implies acceptance of credits throughout the European Union and associated countries.
Glaucoma Now is also recognised by the Royal Australian and New Zealand College of Ophthalmologists as a valid Continuing Professional Development activity.
Since 2013 the program is recognized by the Brazilian Council of Ophthalmology. Brazilian physicians successfully taking CME tests on our website are automatically awarded CME points by CBO.
Issue 2 - 2018 Assessing Function in Glaucoma
Special Focus: A comprehensive overview on optimal testing, taking into account traditional and recent technologies to detect glaucoma damage and progression such as changes in optic disc and SAP, use of OCT, electrophysiology PERG/VEP and others.
What’s New: A review of where are we going with the newest approaches such as OCT, PERG, VEP in the light of the newest clinical data.
Clinical Issues: Insight into an optimal approach to testing: What tests and strategies are to be used for whom and when?
Practical Tips: A practical approach to use of current test methods: Minimizing artifacts and avoiding pitfalls in interpretation.
Special Focus: A comprehensive overview of basic science understanding of glaucoma including mechanisms of damage, cellular effects in neurodegeneration (oxidative stress, protein misfolding, mitochondrial dysfunction), risk factors, parameters measured ( IOP, CCT, OPP, changes in optic disc and OCT findings, electrophysiology PERG/VEP, VF ), outlook and implications.
What’s New: A discussion of why early glaucoma diagnosis is so important, including risk assessment and parameters of detection (RNFL abnormalities, electrophysiology, VF defects) summarizing existing gold standards and giving an outlook on new technologies
Clinical Issues: A review of current techniques in monitoring glaucoma progression, including gold standard HRT, other approaches such as OCT, GDx, PERG/VEP and long-term data
Practical Tips: A summary on all options to manage glaucoma in pregnancy and lactation
Access the latest issue of Glaucoma Now. Each issue focuses on a major theme and is split into four sections: Special Focus, What's New, Clinical Issues and Practical Tips.
Based on the information found in each electronic issue, we offer an associated e-learning course. Individual issues of Glaucoma Now are accredited for Continuing Medical Education (CME).
About Glaucoma Now
Our goal is to educate and update general ophthalmologists, glaucoma specialists and ophthalmology residents. Learn more about our publication, guidelines for authors and our editorial board.
Ivan Goldberg MD, FRANZCO, FRACS, Sydney Eye Hospital, Sydney, NSW, Australia
Remo Susanna Jr MD, Department of Ophthalmology, University of São Paulo, São Paulo, Brazil